Position in ASND
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$17,736,880
-$61,591,115 QoQ
Shares Held
66,500
-85.5% QoQ
Ownership
0.101%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#78
of 307 holders
Holding Since
Mar 2020
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ASND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ADAGE CAPITAL PARTNERS GP, L.L.C. holds $4,240,035,723 across 126 Biotechnology names. ASND ranks #58 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
10,349,328 | $366,262,717 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
1,015,480 | $339,972,549 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
393,964 | $195,693,737 | |
| 4 | TNGX |
Tango Therapeutics, Inc.
|
5,600,000 | $175,056,000 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
2,252,000 | $167,728,960 | |
| 6 | SYRE |
Spyre Therapeutics, Inc.
|
1,722,300 | $152,905,794 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
2,569,356 | $145,965,114 | |
| 8 | RPRX |
Royalty Pharma plc
|
2,500,000 | $140,175,000 |
All Filings in ASND
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,736,880 | 66,500 | Shares | Sole | 2026-08-14 | |
| 2025-06-30 | $79,327,995 | 459,606 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $51,029,343 | 327,405 | Shares | Sole | 2025-05-15 | |
| 2024-09-30 | $72,707,549 | 486,957 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $111,901,426 | 820,512 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $31,671,929 | 209,512 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $18,136,800 | 144,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $49,289,380 | 526,371 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $61,493,250 | 689,000 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $53,610,000 | 500,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $78,163,200 | 640,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $23,749,800 | 230,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $15,338,400 | 165,000 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $20,185,920 | 172,000 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $6,726,500 | 50,000 | Shares | Sole | 2022-02-14 | |
| 2020-06-30 | $4,437,000 | 30,000 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $4,504,400 | 40,000 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||